Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
106.89 USD
-0.65%
Market Closed
Updated:
Apr 25, 2024
Abbott Laboratories
Operating Expenses
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbott Laboratories
Operating Expenses Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Expenses
-$15.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Expenses
-$6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-7%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Expenses
-$7.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Operating Expenses
-$2.9B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-11%
|
|
|
Stryker Corp
NYSE:SYK
|
Operating Expenses
-$8.7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Expenses
-$3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-14%
|
See Also
What is Abbott Laboratories's Operating Expenses?
Operating Expenses
-15.6B
USD
-15.6B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Operating Expenses amounts to -15.6B USD.
What is Abbott Laboratories's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-7%
-7%
Over the last year, the Operating Expenses growth was 2%. The average annual Operating Expenses growth rates for Abbott Laboratories have been -3% over the past three years , -2% over the past five years , and -7% over the past ten years .
You don't have any saved screeners yet
